BDNF and depressive symptom measurement: The observed benefits of AE may be mechanistically explained by regulation of glutamatergic system, the neurotoxic effects of HCY in regulating ionotropic glutamate receptors involved in the pathogenesis of depression, and/or influences in glucocorticoids-BDNF expression interaction.